Haemonetics (HAE) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $107.60 --0%
EPS Growth %: 0.0%
Financial Fact:
Net income: 0.38
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: 0.0%
Financial Fact:
Net income: 0.38
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $228.1 million versus the consensus estimate of $219.42 million.
GUIDANCE:
Haemonetics sees FY2018 EPS of $1.55-$1.65, versus the consensus of $1.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- UBS Upgrades FTC Solar Inc. (FTCI) to Buy
- BofA Securities Reiterates Underperform Rating on HubSpot Inc (HUBS)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
